Chapter 47 Congenital and vascular retinal abnormalities
CONGENITAL HYPERTROPHY OF THE RETINAL PIGMENT EPITHELIUM
CONGENITAL GROUPED PIGMENTATION OF THE RPE
CONGENITAL SIMPLE HAMARTOMA OF THE RETINA
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM
FAMILIAL RETINAL ARTERIOLAR TORTUOSITY
INHERITED RETINAL VENOUS BEADING
CONGENITAL RETINAL MACROVESSEL
INHERITED FAMILIAL RETINAL MACROANEURYSMS
Congenital hypertrophy of the retinal pigment epithelium
Congenital hypertrophy of the retinal pigment epithelium (CHRPE) lesions are pigmented lesions of the retinal pigment epithelium (RPE) that are flat or very slightly raised, round or oval, and predominantly located at the mid-periphery as well as in the peripapillary or macular regions (Fig. 47.1). A pigmented and non-pigmented halo may surround lesions with multiple depigmented lacunae within the lesion. Depigmented CHRPEs are less common.1 Optical coherence tomography (OCT) demonstrates lack of photoreceptors overlying the lesion2 while absent autofluorescence shows a lack of lipofuscin. Fluorescein angiography demonstrates choroidal masking.3
Associations
Vascular sheathing, vessel attenuation and microangiopathy, drusen, adjacent white-without-pressure, and adjacent depigmented linear RPE streaks are found on or around lesions. Lesions gradually enlarge in diameter; 83% of lesions enlarged at a rate of 2 µm/mm lesion-base per month.1 Flat CHRPE are rarely associated with visual loss. A small proportion (1.5%) contain nodules. Visual loss may occur due to macular edema. Exceptionally, malignant transformation occurs within nodular lesions.5
CHRPE associated with adenomatosis polyposis of the colon
The majority of CHRPEs have neither visual nor health implications. However, multiple (more than three), bilateral, mixed pigmented, and depigmented CHRPEs are specific and sensitive markers of adenomatous polyposis of the colon (APC), or familial adenomatous polyposis (FAP). In APC, CHRPEs may be ovoid, pisciform or irregular in shape and may be surrounded by a pale gray halo or an adjacent depigmented linear streak (Fig. 47.2). They vary in size, from dot-like lesions to multiple disk diameters and position.
Genetics
APC is an autosomal dominant disorder, with an incidence of 1 in 83007 that predisposes to malignancy and accounts for ~1% of all colorectal cancers. CHRPEs are associated with Gardner’s syndrome (APC with extracolonic manifestations such as osteoma and desmoid tumors) and Turcot’s syndrome (co-occurrence of FAP and medulloblastoma), and are found in APC families without extracolonic manifestations.7 All are caused by mutations within the APC gene on chromosome 5q21–22.8 CHRPEs are not seen in all individuals with the APC phenotype and when present suggest a mutation between codons 463 and 1387. In families where CHRPEs are present they are highly penetrant.
Most affected individuals with APC develop multiple adenomatous colorectal polyps between the second and fourth decades.9 Malignant transformation occurs in over 90% of patients by age 50 years. Tumor surveillance for gene carriers by colonoscopy begins from around 12 years and usually leads to elective colectomy. Polyps may also develop in the stomach, small bowel, and duodenum, the last being associated with a risk of malignant transformation. Ten percent of patients develop desmoid tumors: benign, locally invasive fibrous tissue tumors. Osteomas of the mandible and dental anomalies, such as missing or supernumerary teeth, are common.
Congenital grouped pigmentation of the RPE
Congenital grouped pigmentation of the RPE is characterized by small, darkly pigmented, flat, circumscribed lesions at the level of the RPE that generally increase in size as they approach the retinal periphery. The lesions resemble animal tracks (“bear tracks”) (Fig. 47.3). They do not affect vision; electrodiagnostic and color vision testing are normal. Mostly, lesions are unilateral and sectoral. Occasionally, the entire fundus may be involved.10 A depigmented variant (“polar bear tracks”) has been described in a sibling of a girl with normal bear tracks.11
Congenital simple hamartoma of the retina
These solitary, rare lesions differ from congenital hypertrophy of the RPE and RPE hyperplasia. They are typically located close to the fovea. They are circumscribed, nodular, and heavily pigmented, arising from the RPE and projecting into the vitreous through the full thickness of the retina. A feeder arteriole and venule are usually present. Subtle surrounding retinal traction may reduce visual acuity. Ultrasound shows a nodular echogenic mass with moderate to high internal reflectivity. Fluorescein angiography demonstrates non-fluorescence with a late, variable, surrounding ring of hyperfluorescence.13 The lesion blocks indocyanine green choroidal fluorescence. OCT shows elevation of the retina at the lesion with enhanced reflectivity of the vitreous face of the lesion and optical shadowing of the retina and choroid.14 The lesions are congenital, stable, and asymptomatic throughout life; intraretinal hemorrhage adjacent to the lesion and intraretinal exudation can occur.13
Torpedo maculopathy
Torpedo maculopathy, or paramacular coloboma, is characterized by an ovoid, sharply defined, non-pigmented lesion in the temporal region of the macula, centered on the horizontal raphe (Fig. 47.3). Lesions are longer horizontally (2–3 mm) than vertically (1 mm) with a characteristic point aimed toward the fovea and either a frayed, pigmented tail or rounded temporal margin (Fig. 47.4). Usually unilateral and solitary, satellite lesions may occur. The margins are sharply defined by a hyperpigmented border.
OCT reveals absent RPE, overlying retinal disorganization and thinning, irregularity and degenerate photoreceptor outer segments.15 Autofluorescence imaging shows hypoautofluorescence within the lesion.16 The foveal architecture and visual acuity are normal.
Retinal astrocytic hamartoma
Retinal astrocytic hamartomas are benign glial tumors of the retinal nerve fiber layer frequently associated with tuberous sclerosis (see Chapter 65). Calcification can cause diagnostic confusion with retinoblastoma, although the mean age at diagnosis of retinoblastoma is around 2 years, whilst that of astrocytoma is 14.5 years.17 Progression from flat to nodular lesions can occur. Most lesions range from 0.5 to 5 mm in diameter. They are slow growing, but very occasionally exhibit more aggressive growth resulting in retinal exudation, vitreous hemorrhage, retinal detachment, retinochoroiditis, neovascular glaucoma, vitreous seeding,18 and globe perforation.19
TSC is associated with mutations in one of two tumor suppressor genes, Hamartin (TSC1) and Tuberin (TSC2). The encoded proteins form a cytoplasmic molecular complex that controls cell growth and survival signals conveyed through the P13K signal transduction pathway.20
Retinal capillary hemangioma
Retinal capillary hemangiomas (RCH), more correctly hemangioblastomas, are circumscribed, orange–red, round, vascular tumors with a prominent feeding and draining vessel (see Chapter 65). When sporadic, they are usually unilateral and unifocal. RCHs are a frequent association with von Hippel-Lindau syndrome (VHL, see Chapter 65), a multisystem, autosomal dominant, familial, cancer-predisposition syndrome. In VHL, the RCHs are often bilateral and multifocal.21 Fluorescein angiography shows early hyperfluorescence, late leakage, and distinguishes feeder vessels from draining venules; it highlights small peripheral RCHs, otherwise undetectable.22 B-scan ultrasound detects a mass lesion, measures basal dimensions, and detects subretinal fluid. A-scans show medium to high internal reflectivity.23 OCT can measure retinal thickness at the macula and monitor treatment response.24
RCHs are mostly located anterior to the equator usually superotemporally or, less frequently (10–15%), in the juxtapapillary region.25 Peripheral RCHs increase in size gradually with surface glial proliferation resulting in striae and traction. Visual loss occurs from leakage and exudation leading to cystoid macular edema, exudative and tractional retinal detachment.26 Neovascular glaucoma or cataract may occur.
Juxtapapillary hemangiomas are typically located temporal to the optic nerve. They may be sessile, usually endophytic or sometimes exophytic;27 they may remain stable for prolonged periods. This, together with close proximity to the optic nerve and the high likelihood of visual loss from nerve damage as a result of treatment, has led to many advocating observation until the macula is threatened by exudation and visual loss.27
Genetics
VHL is an autosomal dominant disorder with an estimated prevalence of 1 in 39 000–53 000. Tumors associated with VHL can occur sporadically; 20% of VHL patients represent de novo mutations. Thus, the diagnosis of VHL depends on a positive family history or the presence of two typical tumors. Organs affected include CNS (hemangioblastomas), pancreas (cysts), kidney (renal cell carcinoma), liver, and adrenal glands (pheochromocytoma). The VHL gene encodes two VHL proteins which regulate proteolytic degradation of hypoxia inducible factors HIF-1 and HIF-2.28
In VHL, onset of hemangioblastomas occurs around 4 years of age and the probability of developing RCHs increases with age often causing visual symptoms by the second decade. Annual screening, beginning at 10 years, is recommended. Manifestation of RCHs mostly occurs by 30 years; adults with normal retinal examination after this age are unlikely to develop tumors.26,29
Management
Treatment for RCHs includes laser photocoagulation, photodynamic therapy (PDT), cryotherapy, plaque radiotherapy, trans-scleral penetrating diathermy, vitreoretinal surgery, and systemic and intravitreal bevacizumab. For small (<1.5 mm in diameter), posteriorly located lesions, laser photocoagulation applied directly to the RCH and the feeder vessels is highly effective.30 More anteriorly located lesions and those with subretinal fluid may best be treated with cryotherapy.30 PDT with verteporfin has been used in both peripheral and juxtapapillary RCHs. PDT has a moderate effect using standard parameters as used in the TAP study.31 Complications include vitreous hemorrhage, subretinal hemorrhage, ischemic optic neuropathy, vascular occlusion, increase in subretinal fluid, and retinal detachment. PDT shows a relatively better outcome in juxtapapillary RCHs; more than one treatment may be required.31
Anti-VEGF (vascular endothelial growth factor) treatments, systemic or intravitreal, provide mixed results with a transient reduction in retinal edema but no significant reduction in tumor size or new tumor development.32,33
Cavernous hemangioma
This rare congenital vascular malformation (hamartoma) of the retina is usually sporadic, occasionally autosomal dominant with incomplete penetrance. Retinal lesions are unilateral and unifocal and, while often isolated, can be associated with intracranial or cutaneous cavernous hemangiomas: a neuro-oculocutaneous phakomatosis.34 Cavernous hemangiomas consist of saccular aneurysms resembling a cluster of grapes anywhere in the inner retina following the course of a retinal vein (Fig. 47.5). Visual loss may occur due to recurrent vitreous hemorrhage or macula involvement. Those located at the optic disk may compress nerve fibers.35 Fluorescein angiography demonstrates delayed filling with hyperfluorescent capping of the saccules. No leakage or exudation occurs.36
Fig. 47.5 Cavernous hemangioma of the retina showing the “grape-like” clusters of saccular aneurysms.
Genetics
Autosomal dominant inheritance has been described; it is recommended to examine first-degree relatives. The coexistence of retinal cavernous hemangioma with cerebral cavernous malformations (CCM) may be associated with three genetic loci (CCM1-3). The three encoded proteins interact in a protein complex involved in the regulation of endothelial cell morphogenesis.37
Management
Neuroimaging is recommended to rule out intracranial involvement. Lesions do not progress with age, frequently have an overlying preretinal glial membrane, and are managed conservatively. Traction may cause spontaneous vitreous hemorrhage.38 Photocoagulation and cryotherapy have been used; regression with intravenous inflixamab has been reported.39
Combined hamartoma of the retina and retinal pigment epithelium
Combined hamartomas of the retina and retinal pigment epithelium (CHRRPEs) are rare benign, usually solitary, unilateral lesions, occasionally bilateral.40 They are congenital, described in infants as young as 2 weeks old.41 Many are non-progressive, but most present with reduced vision, metamorphopsia or strabismus, particularly with macular involvement.
Lesions are slightly elevated with a variable amount of pigment (Fig. 47.6